In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower ...

Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...

Among 2,887 matched pairs, adults with obesity who received the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy) had a 26% lower risk of fracture than those who underwent sleeve gastrectomy ...

Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

Semaglutide can rapidly reduce heart attacks and other serious cardiovascular complications in adults with overweight or ...

ORLANDO — In a retrospective cohort study using propensity matching, among patients with obesity, those taking semaglutide had lower risk for fractures than those who underwent sleeve gastrectomy.

Manhattan-based dentist Dr. Sandip Sachar and obesity medicine specialist Dr. Meghan Garcia-Webb discuss the prevalence of ...

Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...